Therefore, frequent NKX2-2 expression in patients of the closely related B-cell malignancies HL and PMBL may support the significance of this potential oncogene in lymphomagenesis of these particular entities. The gene discussed is NKX2-2; the disease is Hodgkins lymphoma.